Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Bright Minds Biosciences Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 94 | 2 | 99 | +7 |
| Shares | 9.19M | 1.28M | 9.31M | +1.41M (+17.8%) |
| Value | $670.3M | $93.5M | $653.8M | +$77.0M (+13.4%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Bright Minds Biosciences Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jupiter Topco LLC | 1,349,107 | $94.8M | 0.04% |
| Point72 Asset Management, L.P. | 327,416 | $23.0M | 0.04% |
| Citadel Advisors LLC | 66,533 | $4.67M | 0.00% |
| Los Angeles Capital Management LLC | 35,747 | $2.51M | 0.01% |
| Exome Asset Management LLC | 10,110 | $709.7K | 0.44% |
| Two Sigma Investments, LP | 9,606 | $674.3K | 0.00% |
| Tudor Investment Corp Et Al | 8,291 | $582.0K | 0.00% |
| Franklin Resources Inc | 8,020 | $563.0K | 0.00% |
| Arrowstreet Capital, Limited Partnership | 7,199 | $505.4K | 0.00% |
| Alliancebernstein L.P. | 5,680 | $414.5K | 0.00% |
| Engineers Gate Manager LP | 5,412 | $379.9K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1,201 | $84.3K | 0.01% |
| State of Wyoming | 479 | $33.6K | 0.00% |
| Pinnacle Wealth Planning Services, Inc. | 138 | $9.69K | 0.00% |
| Advisor Group Holdings, Inc. | 80 | $5.62K | 0.00% |
| Quarry LP | 27 | $1.90K | 0.00% |
| TD Waterhouse Canada Inc. | 20 | $1.33K | 0.00% |
| SRS Capital Advisors, Inc. | 11 | $772 | 0.00% |
| SJS Investment Consulting Inc. | 5 | $351 | 0.00% |
Sold out (12)
Institutions that held Bright Minds Biosciences Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Perceptive Advisors LLC | 377,544 | $27.5M |
| D. E. Shaw & Co., Inc. | 15,445 | $1.13M |
| SEI Investments Co | 11,188 | $816.4K |
| Ghisallo Capital Management LLC | 11,000 | $802.7K |
| EAM Investors, LLC | 9,189 | $670.5K |
| Quadrature Capital Ltd | 6,498 | $474.2K |
| Susquehanna International Group, LLP | 3,141 | $229.2K |
| Virtu Financial LLC | 3,129 | $228.0K |
| Persistent Asset Partners Ltd | 2,310 | $168.6K |
| GWM Advisors LLC | 250 | $18.2K |
| MAI Capital Management | 1 | $73 |
| Twin Peaks Wealth Advisors, LLC | 1 | $73 |
Not filed for Q2 2026 yet (2)
Institutions that held Bright Minds Biosciences Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 1,284,324 | $93.5M |
| CWM, LLC | 11 | $803 |